Eisai's etalanetug receives FDA fast track designation for Alzheimer's
Tweet Send to a Friend
Eisai Co., Ltd. (TSE: 4523) announced that its investigational anti-tau antibody etalanetug received Fast Track designation from the U.S. Food ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
